Abstract
We performed a prospective study to evaluate the imaging potential of thallium-201 as compared with other imaging modalities in differentiating residual/re-current tumors from post-therapy changes in patients with musculoskeletal sarcomas.201TI scans, magnetic resonance imaging (17), X-ray computed tomography (6) or contrast angiography (6) studies in 29 patients previously treated for musculoskeletal sarcomas were correlated with either histopathologic findings (26 patients) or 2-year clinical follow-up (three patients). All imaging studies were acquired within 2 weeks. Ratios of201T1 tumor uptake to the contralateral (28 patients) or adjacent region of interest were calculated. When qualitative interpretation was in doubt, only those cases with a ratio of 1.5 or more were considered suggestive of recurrent or residual viable tumor tissue. Residual or recurrent tumor tissue was verified in 21 patients by biopsy. All had true-positive201Tl scans while the other imaging modalities were true-positive in 20 and equivocal in one. In eight patients, there was no evidence of viable tumor tissue as proven by biopsy in five and long-term clinical follow-up in three.201Tl scan was false-positive (ratio 1.5) in one patient and true-negative in seven while the other' imaging modalities had four false-positives. The average201T1 ratios were 3.8±1.1 in the true-positive cases and 1.3±0.3 in the true-negative cases. The percentage sensitivities, specificities, and accuracy for201T1 were 100%, 87.5%, and 96.5% versus 95%, 50%, and 82.7% respectively for other imaging modalities These results indicate that201T1 scintigraphy is more accurate than other imaging modalities in differentiating residual/recurrent musculoskeletal sarcomas from post-therapy changes.
Similar content being viewed by others
References
Aisen AM, Martel W, Braunstein EM, et al. MRI and CT evaluation of primary bone and soft-tissue tumors.AJR 1986; 146: 749.
Hudson TM, Hamlin DJ, Enneking WF, et al. Magnetic resonance imaging of bone and soft-tissue tumors: early experience in 31 patients compared with computed tomography.Skeletal Radiol 1985; 13: 134–136.
Petasnick J, Turner D, Charters J, et al. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT.Radiology 1986; 160: 125–133.
Ramannah L, Waxman AD, Weiss A, Rosen G. Thallium-201 (Tl-201) scan patterns in bone and soft tissue sarcoma [abstract].J Nucl Med 1992; 33: 843.
El-Gazzar AH, Malkì A, Abdel-Dayem HM, et al. Role of Tl201 in the diagnosis of solitary bone lesions.Nucl Med Commun 1989; 10: 477–485.
Ramannah L, Waxman AD, Binney G, Waxman S, Mirra J, Rosen G. Tl-201 scintigraphy in bone sarcoma: comparison with Ga-67 and Tc-99m MDP in the evaluation of chemotherapeutic response.J Nucl Med 1990; 31: 567–571.
Kostakoglu L, Abdel-Dayem HM, Yeh SD, Larson SM. A comparative study of thallium-201, CT/MRI/angiography in bone and soft tissue sarcomas: correlation with histologic findings [abstract].J Nucl Med 1992; 33: 843.
Ganz WI, Nguyen TQ, Benedetto MP, et al. Use of early, late and SPECT thallium imaging in evaluating activity of soft tissue and bone tumors [abstract].J Nucl Med 1993; 34: 32P.
Seeger LL, Widoff BE, Bassett LW Rosen G, Eckhardt JJ. Preoperative evaluation of osteosarcoma; value of gadopentetate dimeglumine-enhanced MR imaging.AJR 1991; 157: 347–351.
Kransdorf MS, Jelinek JS, Moser RP Jr, Utz JA, Brower AC, Hudson TM, Berrey BH. Soft tissue masses: diagnosis using MR imaging.AJR 1989; 153: 541–547.
Holscher HC, Bloem JL, Nooy MA, Taminiau AH, Zeulderik F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.AJR 1990; 154: 763–769.
Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.Radiology 1992; 184: 234–238.
Dewhirst MW, Sostman HD, Leopold KA, et al. Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring:Radiology 1990; 174: 847–853.
Lemmi MA, Fletcher BD, Marina NM, Slade W, Parham DM, Jenkins JJ, Meyer WH. Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.AJR 1990; 155: 343–346.
Fletcher BD. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.AJR 1991; 157: 825–833.
Zlatkin MB, Lenkinski RE, Shinkwin M, Schmidt RG, Daly JM, Holland GA, Frank T, Kressel HY. Combined MR imaging and spectroscopy of bone and soft tissue tumors.J Comput Assist Tomogr 1990; 14: 1–10.
Marano I, Brunetti A, Covello M, Belfiore G, Giovine S, Salvatore M. Magnetic resonance in the diagnosis and follow-up of soft-tissue sarcomas.Radiolia Medica 1992; 84: 15–21.
Abdel-Dayem HM, Scott AM, Macapinlac HA, et al. In: Freeman LM, ed.Nuclear medicine annual. New York: Raven Press; 1994: 181–234.
Kern K, Brunetti A, Norton J, Chang A, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET.J Nucl Med 1988; 29: 181–186.
Griffeth L, Dehdashti F, McGuire A, et al. PET evaluation of soft-tissue masses with fluorine- 18-2-deoxy-d-glucose.Radiology 1992; 182: 185–194.
Adler L, Blair H, Makley J, et al. Noninvasive grading of musculoskeletal tumors using PET.J Nucl Med 1991; 32: 1508–1515.
Caner B, Kitapci M, Inlay M, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: comparative study with technetium-99m-MDPJ Nucl Med 1992; 33: 319–324.
Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Softtissue sarcoma: MR imaging vs sonography for detection of local recurrence after therapy.AJR 1991; 157: 353–358.
Venuta S, Ferraiuolo R, Morrone G, et al. The uptake of Tl201 in normal and transformed thyroid cell lines.J Nucl Med Allied Sei 1979; 23: 163–166.
Waxman AD. Thallium-201 in nuclear oncology. In: Freeman LM, ed.Nuclear medicine annual. New York: Raven Press; 1991: 193–209.
Sehweil A, McKillop JH, Ziada G, et al. The optimum time for tumor imaging with thallium-201.Eur J Nucl Med 1988; 13: 527–529.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kostakoglu, L., Panicek, D.M., Divgi, C.R. et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 22, 1232–1237 (1995). https://doi.org/10.1007/BF00801605
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00801605